Summary
Market Overview
The global Radiopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.7% in the forecast period of 2020 to 2025 and will expected to reach USD 7964.2 million by 2025, from USD 5929.1 million in 2019.
The Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Radiopharmaceuticals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Radiopharmaceuticals market has been segmented into Diagnostic Radioisotopes, Therapeutic Radioisotopes, etc.
By Application, Radiopharmaceuticals has been segmented into Oncology, Cardiology, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Radiopharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level Radiopharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Radiopharmaceuticals market.
The report offers in-depth assessment of the growth and other aspects of the Radiopharmaceuticals market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Radiopharmaceuticals markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Radiopharmaceuticals Market Share Analysis
Radiopharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Radiopharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Radiopharmaceuticals sales, revenue and market share for each player covered in this report.
The major players covered in Radiopharmaceuticals are: Bracco Imaging, GE Healthcare, Nordion, Bayer, IBA Group, Mallinckrodt, Jubilant Pharma, Lantheus, Triad Isotopes, China Isotope & Radiation, Navidea, Eli Lilly, Dongcheng, Advanced Accelerator Applications, SIEMENS, etc. Among other players domestic and global, Radiopharmaceuticals market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals, with price, sales, revenue and global market share of Radiopharmaceuticals in 2018 and 2019.
Chapter 3, the Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Overview of Global Radiopharmaceuticals Market
1.4.1 Global Radiopharmaceuticals Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bracco Imaging SWOT Analysis
2.1.4 Bracco Imaging Product and Services
2.1.5 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GE Healthcare SWOT Analysis
2.2.4 GE Healthcare Product and Services
2.2.5 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nordion
2.3.1 Nordion Details
2.3.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Nordion SWOT Analysis
2.3.4 Nordion Product and Services
2.3.5 Nordion Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 IBA Group
2.5.1 IBA Group Details
2.5.2 IBA Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 IBA Group SWOT Analysis
2.5.4 IBA Group Product and Services
2.5.5 IBA Group Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mallinckrodt
2.6.1 Mallinckrodt Details
2.6.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mallinckrodt SWOT Analysis
2.6.4 Mallinckrodt Product and Services
2.6.5 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Jubilant Pharma
2.7.1 Jubilant Pharma Details
2.7.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Jubilant Pharma SWOT Analysis
2.7.4 Jubilant Pharma Product and Services
2.7.5 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lantheus SWOT Analysis
2.8.4 Lantheus Product and Services
2.8.5 Lantheus Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Triad Isotopes
2.9.1 Triad Isotopes Details
2.9.2 Triad Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Triad Isotopes SWOT Analysis
2.9.4 Triad Isotopes Product and Services
2.9.5 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 China Isotope & Radiation
2.10.1 China Isotope & Radiation Details
2.10.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 China Isotope & Radiation SWOT Analysis
2.10.4 China Isotope & Radiation Product and Services
2.10.5 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Navidea
2.11.1 Navidea Details
2.11.2 Navidea Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Navidea SWOT Analysis
2.11.4 Navidea Product and Services
2.11.5 Navidea Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Eli Lilly SWOT Analysis
2.12.4 Eli Lilly Product and Services
2.12.5 Eli Lilly Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Dongcheng
2.13.1 Dongcheng Details
2.13.2 Dongcheng Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Dongcheng SWOT Analysis
2.13.4 Dongcheng Product and Services
2.13.5 Dongcheng Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Advanced Accelerator Applications
2.14.1 Advanced Accelerator Applications Details
2.14.2 Advanced Accelerator Applications Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Advanced Accelerator Applications SWOT Analysis
2.14.4 Advanced Accelerator Applications Product and Services
2.14.5 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 SIEMENS
2.15.1 SIEMENS Details
2.15.2 SIEMENS Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 SIEMENS SWOT Analysis
2.15.4 SIEMENS Product and Services
2.15.5 SIEMENS Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Radiopharmaceuticals Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Radiopharmaceuticals Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Radiopharmaceuticals Manufacturer Market Share in 2019
3.3.2 Top 6 Radiopharmaceuticals Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Radiopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Radiopharmaceuticals Sales and Market Share by Regions (2015-2020)
4.1.2 Global Radiopharmaceuticals Revenue and Market Share by Regions (2015-2020)
4.2 North America Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.3 Europe Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.5 South America Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Radiopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
5.1.2 North America Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
5.2 United States Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Canada Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Mexico Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Radiopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
6.1.2 Europe Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
6.2 Germany Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 UK Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 France Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Russia Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 Italy Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Radiopharmaceuticals Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Radiopharmaceuticals Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Radiopharmaceuticals Revenue and Market Share by Regions (2015-2020)
7.2 China Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.3 Japan Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Korea Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 India Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.7 Australia Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Radiopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
8.1.2 South America Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
8.2 Brazil Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.3 Argentina Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Radiopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.3 Turkey Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Africa Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Radiopharmaceuticals Sales and Market Share by Type (2015-2020)
10.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2015-2020)
10.3 Global Radiopharmaceuticals Price by Type (2015-2020)
11 Global Radiopharmaceuticals Market Segment by Application
11.1 Global Radiopharmaceuticals Sales Market Share by Application (2015-2020)
11.2 Global Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
11.3 Global Radiopharmaceuticals Price by Application (2015-2020)
12 Market Forecast
12.1 Global Radiopharmaceuticals Sales, Revenue and Growth Rate (2021-2025)
12.2 Radiopharmaceuticals Market Forecast by Regions (2021-2025)
12.2.1 North America Radiopharmaceuticals Market Forecast (2021-2025)
12.2.2 Europe Radiopharmaceuticals Market Forecast (2021-2025)
12.2.3 Asia-Pacific Radiopharmaceuticals Market Forecast (2021-2025)
12.2.4 South America Radiopharmaceuticals Market Forecast (2021-2025)
12.2.5 Middle East & Africa Radiopharmaceuticals Market Forecast (2021-2025)
12.3 Radiopharmaceuticals Market Forecast by Type (2021-2025)
12.3.1 Global Radiopharmaceuticals Sales Forecast by Type (2021-2025)
12.3.2 Global Radiopharmaceuticals Market Share Forecast by Type (2021-2025)
12.4 Radiopharmaceuticals Market Forecast by Application (2021-2025)
12.4.1 Global Radiopharmaceuticals Sales Forecast by Application (2021-2025)
12.4.2 Global Radiopharmaceuticals Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Radiopharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Radiopharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 8. Bracco Imaging Radiopharmaceuticals Major Business
Table 9. Bracco Imaging Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 10. Bracco Imaging SWOT Analysis
Table 11. Bracco Imaging Radiopharmaceuticals Product and Services
Table 12. Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 14. GE Healthcare Radiopharmaceuticals Major Business
Table 15. GE Healthcare Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 16. GE Healthcare SWOT Analysis
Table 17. GE Healthcare Radiopharmaceuticals Product and Services
Table 18. GE Healthcare Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Nordion Basic Information, Manufacturing Base and Competitors
Table 20. Nordion Radiopharmaceuticals Major Business
Table 21. Nordion Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 22. Nordion SWOT Analysis
Table 23. Nordion Radiopharmaceuticals Product and Services
Table 24. Nordion Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bayer Basic Information, Manufacturing Base and Competitors
Table 26. Bayer Radiopharmaceuticals Major Business
Table 27. Bayer Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 28. Bayer SWOT Analysis
Table 29. Bayer Radiopharmaceuticals Product and Services
Table 30. Bayer Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. IBA Group Basic Information, Manufacturing Base and Competitors
Table 32. IBA Group Radiopharmaceuticals Major Business
Table 33. IBA Group Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 34. IBA Group SWOT Analysis
Table 35. IBA Group Radiopharmaceuticals Product and Services
Table 36. IBA Group Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 38. Mallinckrodt Radiopharmaceuticals Major Business
Table 39. Mallinckrodt Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 40. Mallinckrodt SWOT Analysis
Table 41. Mallinckrodt Radiopharmaceuticals Product and Services
Table 42. Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Jubilant Pharma Radiopharmaceuticals Major Business
Table 45. Jubilant Pharma Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 46. Jubilant Pharma SWOT Analysis
Table 47. Jubilant Pharma Radiopharmaceuticals Product and Services
Table 48. Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Lantheus Basic Information, Manufacturing Base and Competitors
Table 50. Lantheus Radiopharmaceuticals Major Business
Table 51. Lantheus Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 52. Lantheus SWOT Analysis
Table 53. Lantheus Radiopharmaceuticals Product and Services
Table 54. Lantheus Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 56. Triad Isotopes Radiopharmaceuticals Major Business
Table 57. Triad Isotopes Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 58. Triad Isotopes SWOT Analysis
Table 59. Triad Isotopes Radiopharmaceuticals Product and Services
Table 60. Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 62. China Isotope & Radiation Radiopharmaceuticals Major Business
Table 63. China Isotope & Radiation Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 64. China Isotope & Radiation SWOT Analysis
Table 65. China Isotope & Radiation Radiopharmaceuticals Product and Services
Table 66. China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Navidea Basic Information, Manufacturing Base and Competitors
Table 68. Navidea Radiopharmaceuticals Major Business
Table 69. Navidea Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 70. Navidea SWOT Analysis
Table 71. Navidea Radiopharmaceuticals Product and Services
Table 72. Navidea Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly Radiopharmaceuticals Major Business
Table 75. Eli Lilly Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 76. Eli Lilly SWOT Analysis
Table 77. Eli Lilly Radiopharmaceuticals Product and Services
Table 78. Eli Lilly Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 80. Dongcheng Radiopharmaceuticals Major Business
Table 81. Dongcheng Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 82. Dongcheng SWOT Analysis
Table 83. Dongcheng Radiopharmaceuticals Product and Services
Table 84. Dongcheng Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 86. Advanced Accelerator Applications Radiopharmaceuticals Major Business
Table 87. Advanced Accelerator Applications Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 88. Advanced Accelerator Applications SWOT Analysis
Table 89. Advanced Accelerator Applications Radiopharmaceuticals Product and Services
Table 90. Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 92. SIEMENS Radiopharmaceuticals Major Business
Table 93. SIEMENS Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 94. SIEMENS SWOT Analysis
Table 95. SIEMENS Radiopharmaceuticals Product and Services
Table 96. SIEMENS Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Radiopharmaceuticals Sales by Manufacturer (2018-2019) (K Dose)
Table 98. Global Radiopharmaceuticals Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Radiopharmaceuticals Sales by Regions (2015-2020) (K Dose)
Table 100. Global Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 101. Global Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Radiopharmaceuticals Sales by Countries (2015-2020) (K Dose)
Table 103. North America Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 104. North America Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 106. Europe Radiopharmaceuticals Sales by Countries (2015-2020) (K Dose)
Table 107. Europe Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 108. Europe Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Radiopharmaceuticals Sales by Regions (2015-2020) (K Dose)
Table 110. Asia-Pacific Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Radiopharmaceuticals Sales by Countries (2015-2020) (K Dose)
Table 113. South America Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 114. South America Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Radiopharmaceuticals Sales by Countries (2015-2020) (K Dose)
Table 117. Middle East & Africa Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 120. Global Radiopharmaceuticals Sales by Type (2015-2020) (K Dose)
Table 121. Global Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 122. Global Radiopharmaceuticals Revenue by Type (2015-2020) (USD Million)
Table 123. Global Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 124. Global Radiopharmaceuticals Sales by Application (2015-2020) (K Dose)
Table 125. Global Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 126. Global Radiopharmaceuticals Sales Forecast by Regions (2021-2025) (K Dose)
Table 127. Global Radiopharmaceuticals Market Share Forecast by Regions (2021-2025)
Table 128. Global Radiopharmaceuticals Sales Forecast by Type (2021-2025) (K Dose)
Table 129. Global Radiopharmaceuticals Market Share Forecast by Type (2021-2025)
Table 130. Global Radiopharmaceuticals Sales Forecast by Application (2021-2025)
Table 131. Global Radiopharmaceuticals Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Radiopharmaceuticals Picture
Figure 2. Global Sales Market Share of Radiopharmaceuticals by Type in 2019
Figure 3. Diagnostic Radioisotopes Picture
Figure 4. Therapeutic Radioisotopes Picture
Figure 5. Radiopharmaceuticals Sales Market Share by Application in 2018
Figure 6. Oncology Picture
Figure 7. Cardiology Picture
Figure 8. Other Picture
Figure 9. Global Radiopharmaceuticals Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Radiopharmaceuticals Sales Market Share by Manufacturer in 2019
Figure 30. Global Radiopharmaceuticals Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 35. Global Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure 37. Global Radiopharmaceuticals Revenue Market Share by Regions in 2018
Figure 38. North America Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 39. Europe Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 41. South America Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 43. North America Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure 45. North America Radiopharmaceuticals Sales Market Share by Countries in 2018
Figure 46. North America Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Radiopharmaceuticals Revenue Market Share by Countries in 2018
Figure 48. United States Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 49. Canada Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 50. Mexico Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 51. Europe Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 54. Germany Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 55. UK Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 56. France Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 57. Russia Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 58. Italy Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 59. Asia-Pacific Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Radiopharmaceuticals Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Radiopharmaceuticals Revenue Market Share by Regions 2019
Figure 62. China Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 63. Japan Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 64. Korea Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 65. India Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 66. Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 67. South America Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Radiopharmaceuticals Sales Market Share by Countries in 2019
Figure 69. South America Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 70. Brazil Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 71. Argentina Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 72. Middle East and Africa Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Radiopharmaceuticals Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 77. Egypt Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 78. Turkey Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 79. South Africa Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Dose)
Figure 80. Global Radiopharmaceuticals Sales and Growth Rate (2021-2025) (K Dose)
Figure 81. Global Radiopharmaceuticals Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Radiopharmaceuticals Market Forecast (2021-2025) (K Dose)
Figure 83. Europe Sales Radiopharmaceuticals Market Forecast (2021-2025) (K Dose)
Figure 84. Asia-Pacific Sales Radiopharmaceuticals Market Forecast (2021-2025) (K Dose)
Figure 85. South America Sales Radiopharmaceuticals Market Forecast (2021-2025) (K Dose)
Figure 86. Middle East & Africa Sales Radiopharmaceuticals Market Forecast (2021-2025) (K Dose)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy